PGA-dopamine conjugates (PGAPDA) were synthesized and assembled onto silica particles to yield biodegradable capsules with tunable degradation properties. Increasing the dopamine content results in thicker films with a concomitant reduction in the degradation kinetics. These tailored capsules are expected to find application in diverse areas, including drug and gene delivery.
No takes yet. Share an insight, caveat, or question.
Ochs et al. (2011) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: